Viking Therapeutics (VKTX) Prepaid Assets (2014 - 2026)
Viking Therapeutics (VKTX) reported Prepaid Assets of $1.2 million for Q1 2026, up 41.5% on a YoY basis from $865000.0 in Q1 2025, and down 32.23% sequentially from $1.8 million in Q4 2025.
Viking Therapeutics (VKTX) Prepaid Assets (2014 - 2026) Analysis & Trends
Viking Therapeutics (VKTX) has 13 years of Prepaid Assets data on file, last reported at $1.2 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 41.5% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (up 41.5% YoY), and the FY2025 full-year result was $1.8 million, up 60.11% from the prior year.
- Prepaid Assets fell to $1.2 million in Q1 2026, from $1.8 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $3.9 million in Q1 2023 to a low of $138000.0 in Q2 2024.
- A 5-year average of $1.6 million and a median of $1.1 million in 2024 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets plunged 85.62% in 2024 and soared 1939.86% in 2025, its largest moves.
- Tracing VKTX's Prepaid Assets over 5 years: stood at $3.4 million in 2022, then fell by 26.06% to $2.5 million in 2023, then plunged by 55.27% to $1.1 million in 2024, then surged by 60.11% to $1.8 million in 2025, then sank by 32.23% to $1.2 million in 2026.
- Business Quant data shows VKTX's Prepaid Assets at $1.2 million in Q1 2026, $1.8 million in Q4 2025, and $2.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Viking Therapeutics | 4.09 Bn | 4.09 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.22 Mn |
| Dec 31, 2025 | 1.81 Mn |
| Sep 30, 2025 | 2.24 Mn |
| Jun 30, 2025 | 2.82 Mn |
| Mar 31, 2025 | 865,000.00 |
| Dec 31, 2024 | 1.13 Mn |
| Sep 30, 2024 | 1.73 Mn |
| Jun 30, 2024 | 138,000.00 |
| Mar 31, 2024 | 643,000.00 |
| Dec 31, 2023 | 2.52 Mn |
| Sep 30, 2023 | 670,000.00 |
| Jun 30, 2023 | 960,000.00 |
| Mar 31, 2023 | 3.93 Mn |
| Dec 31, 2022 | 3.41 Mn |
| Sep 30, 2022 | 956,000.00 |
| Jun 30, 2022 | 1.09 Mn |
| Mar 31, 2022 | 388,000.00 |
| Dec 31, 2021 | 619,000.00 |
| Sep 30, 2021 | 915,000.00 |
| Jun 30, 2021 | 1.15 Mn |